Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 1/20 | 0.47 |
| ▸ | ACHE | P22303 | 1/20 | 0.47 |
| ▸ | ESR1 | P03372 | 1/20 | 0.45 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.45 |
| ▸ | MGAM | O43451 | 4/20 | 0.44 |
| ▸ | GAA | P10253 | 4/20 | 0.44 |
| ▸ | SI | P14410 | 4/20 | 0.44 |
| ▸ | MGAM2 | Q2M2H8 | 4/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20152195 | 0.97 | BCHE (0.48) | BCHEACHEESR1ESR2MGAM | |
| SCHEMBL12124998 | 0.86 | BCHE (0.47) | BCHEACHEESR1ESR2MGAM | |
| SCHEMBL10246659 | 0.86 | BCHE (0.47) | BCHEACHEESR1ESR2MGAM | |
| SCHEMBL9888858 | 0.85 | BCHE (0.47) | BCHEACHEESR1ESR2MGAM | |
| SCHEMBL20152231 | 0.83 | ESR2 (0.65) | ESR1ESR2GAAMEN1HSP90AA1 | |
| SCHEMBL18708370 | 0.82 | ESR1 (0.63) | ESR1ESR2GAAMEN1HSP90AA1 | |
| SCHEMBL804998 | 0.82 | GAA (0.47) | BCHEACHEMGAMGAASI | |
| SCHEMBL20152156 | 0.82 | KDM4E (0.46) | ESR1ESR2GAAMEN1HSP90AA1 | |
| SCHEMBL2173277 | 0.81 | BCHE (0.65) | BCHEACHEESR1ESR2MGAM | |
| SCHEMBL19653957 | 0.81 | L3MBTL1 (0.47) | ESR1ESR2GAAMEN1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10662196-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2020-05-26 | — | — | US | disclosed |
| US-20180134718-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION | 2018-05-17 | — | — | US | disclosed |
| US-20180134718-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION | 2018-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10662196-B2 | Organic electroluminescent materials and devices | OCIAD2, OCIAD1, SLCO4C1 | BCHE 1904/4885ACHE 1071/4885ESR1 949/4885 |
| US-20180134718-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, OCIAD1, SLCO4C1 | BCHE 1904/4885ACHE 1071/4885ESR1 949/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.